Clay Patrick G, Glaros Alan G, Clauson Kevin A
Associate Professor and Director of Dybedal Clinical Research Center, Kansas City, MO, USA.
Ann Pharmacother. 2006 Mar;40(3):427-32. doi: 10.1345/aph.1E497. Epub 2006 Feb 28.
Evidence exists that medically indigent and minority patients use dietary supplements at rates as high or higher than that of the general population. Safety concerns regarding the use of dietary supplements are further exacerbated by a suboptimal level of patient disclosure and provider inquiry.
To determine dietary supplement use, indications, perceived efficacy, and information sources of patients and providers using a pilot study in a clinic for the medically indigent.
Five hundred self-administered patient surveys and 50 healthcare provider surveys were made available to any patient at a free health clinic in Kansas City, MO. Surveys were collected and descriptive analyses were performed.
Three hundred eleven patient surveys were returned. Of the 37.3% (116/311) of respondents who had used dietary supplements, 13.8% (n = 16) had 10 comorbid conditions. Ninety-six dietary supplements were used for 8 medical condition categories. The 9 agents most frequently reported used were garlic (n = 32), aloe/green tea (n = 27 each), chamomile/echinacea (n = 24 each), St. John's wort (n = 22), ginseng (n = 18), and cranberry/Ginkgo biloba (n = 17 each). Patients reported a broad range of indications for taking dietary supplements. Patients reported (mean +/- SD) 2.37 +/- 4.23 agents as effective and 0.78 +/- 1.73 as ineffective or harmful. Provider surveys revealed that 60% (21/35) and 74% (26/35) were currently or had ever used dietary supplements, respectively. Fifty-seven percent (20/35) of providers reported attending educational programs on dietary supplements, and providers perceived patient supplement use to be most influenced by advertisements (40%) and friends (40%).
The medically indigent population uses a wide variety of dietary supplements. There is little consistency in perceived indications, which may prevent clinicians from accurately predicting specific herbal use rationale given any individual's or population's set of comorbid conditions. Clinicians are encouraged to accurately determine their individual practice setting's use pattern.
有证据表明,医疗贫困患者和少数族裔患者使用膳食补充剂的比例与普通人群相当或更高。患者披露信息不足以及医疗服务提供者询问不够充分,进一步加剧了对使用膳食补充剂的安全担忧。
通过在一家为医疗贫困者服务的诊所进行的试点研究,确定患者和医疗服务提供者使用膳食补充剂的情况、适应证、感知疗效及信息来源。
在密苏里州堪萨斯城的一家免费诊所,向所有患者提供500份患者自填式调查问卷和50份医疗服务提供者调查问卷。收集调查问卷并进行描述性分析。
共收回311份患者调查问卷。在使用过膳食补充剂的37.3%(116/311)的受访者中,13.8%(n = 16)有10种合并症。96种膳食补充剂用于8类医疗状况。最常报告使用的9种制剂为大蒜(n = 32)、芦荟/绿茶(各n = 27)、洋甘菊/紫锥菊(各n = 24)、圣约翰草(n = 22)、人参(n = 18)以及蔓越莓/银杏叶(各n = 17)。患者报告了服用膳食补充剂的广泛适应证。患者报告(均值±标准差)2.37 ± 4.23种制剂有效,0.78 ± 1.73种制剂无效或有害。医疗服务提供者调查问卷显示,分别有60%(21/35)和74%(26/35)的人目前或曾经使用过膳食补充剂。57%(20/35)的医疗服务提供者报告参加过关于膳食补充剂的教育项目,且医疗服务提供者认为患者使用补充剂受广告(40%)和朋友(40%)的影响最大。
医疗贫困人群使用多种膳食补充剂。在感知的适应证方面几乎没有一致性,这可能使临床医生难以根据个体或人群的合并症准确预测特定草药的使用理由。鼓励临床医生准确确定其个人执业环境中的使用模式。